INS and metabolic dysfunction-associated steatotic liver disease: Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disease in the world (Younossi et al., 2017) and is characterized by an excess of liver fat, tissue injury, and insulin resistance (Korenblat et al., 2008; Hardy et al., 2016; Diehl and Day, 2017).